Atria Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,698
Closed -$272K 2061
2025
Q4
$272K Sell
6,698
-1,008
-13% -$43.9K ﹤0.01% 1790
2025
Q3
$362K Sell
7,706
-6,125
-44% -$318K ﹤0.01% 1610
2025
Q2
$720K Sell
13,831
-982
-7% -$53.9K 0.01% 1221
2025
Q1
$895K Buy
14,813
+3,057
+26% +$197K 0.01% 1043
2024
Q4
$805K Sell
11,756
-2,460
-17% -$171K 0.01% 1095
2024
Q3
$1.02M Buy
14,216
+3,189
+29% +$225K 0.01% 961
2024
Q2
$764K Buy
+11,027
New +$804K 0.01% 1078

Other funds holding CNMD

Atria Investments's CNMD Position: Q1 2026 in Review

Atria Investments sold out of CONMED (CNMD) in Q1 2026, closing a stake of 6,698 shares — an estimated $272K sold.

Atria Investments first reported a position in CNMD in Q2 2024 and held it in 7 quarters. The position peaked at $1.02M in Q3 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Atria Investments reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Atria Investments sold 6,698 CONMED shares in Q1 2026, an estimated $272K.
  • Atria Investments first reported a position in CONMED in Q2 2024 and held it in 7 quarters.
  • Atria Investments's CONMED position peaked at $1.02M in Q3 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.